Ufuk Kumrulu – Chairman, Polifarma
Polifarma is a Turkish pharma company dedicated to the hospital sector and biosimilars. Its chairman, Ufuk Kumrulu, explains how the company has managed to become a top two company in…
Liba was founded in 1945, receıving its name from its two founders, names: Lale and Necip Barlas. Lale Barlas was one of the first women pharmacists in Turkey, also teaching chemistry; Necip Barlas was a businessman, having studied economics.
They began their enterprise by making “cold tissues” in their apartment. Liba diversified its spectrum of products, and moved to Provayans Han in Tahtakale in 1946, then to Karaköy Perşembe Pazarı in 1948. In 1966 it received its status as an Incorporated Company, becoming Liba Laboratories Inc. The company then moved to Ortaköy Palanga Cad. in 1972, where it thrived for 22 years, and finally moved to its current building in Kavacık.
Today, Liba represents companies including Gerot Pharmazuetika, Alcon Pharmaceuticals (a Novartis company), Reckitt Benckiser, and others.
Liba Laboratuarları A.Ş.
Otağtepe Cad. No:5
Kavacık Anadoluhisarı,
İstanbul – Türkiye
Tel: +90 216 465 38 85
Fax: +90 216 465 38 80
info@liba.com.tr
Polifarma is a Turkish pharma company dedicated to the hospital sector and biosimilars. Its chairman, Ufuk Kumrulu, explains how the company has managed to become a top two company in…
Drawing on over a dozen interviews with C-level pharmaceutical industry executives in Turkey, PharmaBoardroom has compiled a strategic overview of Turkey’s pharma talent potential, including what local talent can offer…
The president of the Investment Office of the Presidency of the Republic of Turkey, Burak Dağlıoğlu, outlines the country’s current economic situation after posting the second-highest GDP growth among G20…
Muzaffer Bal, CEO of Ali Raif, a Turkish generics firm, highlights the company’s new investment in a manufacturing plant, their refusal to follow the trend of Turkish local companies investing…
Süha Taşpolatoğlu, CEO of Abdi Ibrahim, Turkish pharma’s “national champion”, discusses the company’s ambitious bet on biosimilars, their position as the licensing and CMO partner of choice for multinational companies…
Ilko Pharmaceuticals is a family-owned Turkish generics and biosimilars company. General Manager Hatice Öncel explains the company’s investment in biosimilars in collaboration with South Korea’s Genexine and how recent success…
Dr Hamdi Akan, head of Turkey’s Clinical Research Association, dives into the country’s opportunities and barriers to become a clinical trials hub, including the world-class infrastructure and the need for…
İsmail Yormaz, Recordati’s VP and regional director for south-east, highlights how the Milan-based company has become a shining example of a successful localization strategy, upcoming launches and investments, as well…
Almost two decades after initiating large-scale health system reforms, Turkey has consolidated the provision of universal healthcare coverage to over 95 percent of the population. The effort, part of the…
Takeda’s general manager for Turkey, Şeyda Atadan Memiş, reflects on the Japanese giant’s ambitions in Turkey at a pivotal moment when the Shire integration has been completed. Atadan discusses how…
TITCK is the regulatory agency in charge of ensuring the safety of medicines, health products, cosmetics, and personal care products in Turkey. Its recently appointed president, Dr Tolga Karakan, discusses…
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
See our Cookie Privacy Policy Here